Budget Impact of Enzalutamide for Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

por Bui, Cat N., O’Day, Ken, Flanders, Scott, Oestreicher, Nina, Francis, Peter, Posta, Linda, Popelar, Breanna, Tang, Hong, Balk, Mark
Publicado 2016

Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive Bladder

por Perk, Sinem, Wielage, Ronald C., Campbell, Noll L., Klein, Timothy M., Perkins, Anthony, Posta, Linda M., Yuran, Thomas, Klein, Robert W., Ng, Daniel B.
Publicado 2016